Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Retained Earnings (2020 - 2025)

SOPHiA GENETICS's Retained Earnings history spans 6 years, with the latest figure at -$519.3 million for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 17.94% to -$519.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$519.3 million, a 17.94% decrease, with the full-year FY2025 number at -$519.3 million, down 17.94% from a year prior.
  • Retained Earnings hit -$519.3 million in Q4 2025 for SOPHiA GENETICS, down from -$500.1 million in the prior quarter.
  • Over the last five years, Retained Earnings for SOPH hit a ceiling of -$168.7 million in Q2 2021 and a floor of -$519.3 million in Q4 2025.
  • Historically, Retained Earnings has averaged -$350.7 million across 5 years, with a median of -$353.7 million in 2023.
  • Biggest five-year swings in Retained Earnings: crashed 54.99% in 2022 and later fell 16.54% in 2024.
  • Tracing SOPH's Retained Earnings over 5 years: stood at -$211.4 million in 2021, then tumbled by 41.38% to -$298.8 million in 2022, then dropped by 26.43% to -$377.8 million in 2023, then decreased by 16.54% to -$440.3 million in 2024, then decreased by 17.94% to -$519.3 million in 2025.
  • Business Quant data shows Retained Earnings for SOPH at -$519.3 million in Q4 2025, -$500.1 million in Q3 2025, and -$480.1 million in Q2 2025.